Curriculum Vitae

PROF. DR. ONG TENG AIK

Professor
  • Department of Surgery
    Faculty of Medicine
  • taong
  • 0379492441

AREAS OF EXPERTISE

  • UROLOGY

ACADEMIC QUALIFICATION

  • FRCS (Urology), (Urology)
    Royal College of Surgeons in Ireland, UK
  • FEBU, (Urology)
    European Board of Urology
  • MASTER OF SURGERY, UM (2002), (Surgery)
    Universiti Malaya (UM)
  • FRCSI, (Surgery)
    Royal College of Surgeons in Ireland
  • MBBS, UM (1995), (Medicine and Surgery)
    Universiti Malaya (UM)

ADMINISTRATIVE DUTIES

  • Deputy Dean (Value Creation and Enterprise)
    01 Aug 2022 - 15 May 2024 (Dean's Office, Faculty of Medicine)
  • Head of Department
    03 Nov 2020 - 31 Jul 2022 (Department of Surgery, Faculty of Medicine)
  • Committee Member
    04 Nov 2020 - 04 Nov 2021 (University Malaya)
  • Head Coordinator
    01 Apr 2013 - 31 Mar 2015 (Department of Surgery, Faculty of Medicine)

AWARD AND STEWARDSHIP

  • Outstanding Webcast on SIU Academy
    Societie Internationale d'Urologie, 2023 (International)
  • Fellowship of the Academy of Science Malaysia
    Academy of Science Malaysia, 2023 (National)
  • CERTIFICATE OF EXCELLENT SERVICE
    University of Malaya, 2018 (University)
  • CERTIFICATE OF EXCELLENT SERVICE
    University of Malaya, 2016 (University)
  • CERTIFICATE OF EXCELLENT SERVICE
    University of Malaya, 2015 (University)
  • Poster Merit Award for Paper: Doctors' Approaches to Decision Support in Counselling Patients with Prostate Cancer
    WONCA Asia Pacific Regional Conference 2014, 2014 (International)
  • CERTIFICATE OF EXCELLENT SERVICE
    University of Malaya, 2013 (University)
  • Asian Preceptorship Programme
    Singapore General Hospital, 2010 (International)

PUBLICATIONS

Article in Journal
WoS
  1. Shah, Rupin; Agarwal, Ashok; Kavoussi, Parviz; Rambhatla, Amarnath; Saleh, Ramadan; Cannarella, Rossella; Harraz, Ahmed M.; Boitrelle, Florence; Kuroda, Shinnosuke; Hamoda, Taha Abo-Almagd Abdel-Meguid; Zini, Armand; Ko, Edmund; Calik, Gokhan; Toprak, Tuncay; Kandil, Hussein; Gul, Murat; Parekh, Neel; Russo, Giorgio Ivan; Tadros, Nicholas; Kadioglu, Ates; Arafa, Mohamed; Chung, Eric; Rajmil, Osvaldo; Dimitriadis, Fotios; Malhotra, Vineet; Salvio, Gianmaria; Henkel, Ralf; Le, Tan, V; Sogutdelen, Emrullah; Vij, Sarah; Alarbid, Abdullah; Gudeloglu, Ahmet; Tsujimura, Akira; Calogero, Aldo E.; El Meliegy, Amr; Crafa, Andrea; Kalkanli, Arif; Baser, Aykut; Hazir, Berk; Giulioni, Carlo; Cho, Chak-Lam; Ho, Christopher C. K.; Salzano, Ciro; Zylbersztejn, Daniel Suslik; Tien, Dung Mai Ba; Pescatori, Edoardo; Borges, Edson; Serefoglu, Ege Can; Sais-Hamza, Emine; Huyghe, Eric; Ceyhan, Erman; Caroppo, Ettore; Castiglioni, Fabrizio; Bahar, Fahmi; Gokalp, Fatih; Lombardo, Francesco; Gadda, Franco; Duarsa, Gede Wirya Kusuma; Pinggera, Germar-Michael; Busetto, Gian Maria; Balercia, Giancarlo; Cito, Gianmartin; Blecher, Gideon; Franco, Giorgio; Liguori, Giovanni; Elbardisi, Haitham; Keskin, Hakan; Lin, Haocheng; Taniguchi, Hisanori; Park, Hyun Jun; Ziouziou, Imad; de la Rosette, Jean; Hotaling, Jim; Ramsay, Jonathan; Corral Molina, Juan Manuel; Lo, Ka Lun; Bocu, Kadir; Khalafalla, Kareim; Bowa, Kasonde; Okada, Keisuke; Nagao, Koichi; Chiba, Koji; Hakim, Lukman; Makarounis, Konstantinos; Hehemann, Marah; Pena, Marcelo Rodriguez; Falcone, Marco; Bendayan, Marion; Martinez, Marlon; Timpano, Massimiliano; Altan, Mesut; Fode, Mikkel; Al-Marhoon, Mohamed S.; Gilani, Mohammad Ali Sadighi; Soebadi, Mohammad Ayodhia; Gherabi, Nazim; Sofikitis, Nikolaos; Kahraman, Oguzhan; Birowo, Ponco; Kothari, Priyank; Sindhwani, Puneet; Javed, Qaisar; Ambar, Rafael F.; Kosgi, Raghavender; Abou Ghayda, Ramy; Adriansjah, Ricky; Condorelli, Rosita Angela; La Vignera, Sandro; Micic, Sava; Kim, Shannon Hee Kyung; Fukuhara, Shinichiro; Ahn, Sun Tae; Mostafa, Taymour; Ong, Teng Aik; Takeshima, Teppei; Amano, Toshiyasu; Barrett, Trenton; Arslan, Umut; Karthikeyan, Vilvapathy Senguttuvan; Atmoko, Widi; Yumura, Yasushi; Yuan, Yiming; Kato, Yuki; Jezek, Davor; Cheng, Bryan Kwun-Chung; Hatzichristodoulou, Georgios; Dy, Jun; Ruiz Castane, Eduard; El-Sakka, Ahmed, I; Bakircioglu, Mustafa Emre; Nguyen, Quang; Sarikaya, Selcuk; Boeri, Luca; Tan, Ronny; Moussa, Mohamad A.; El-Assmy, Ahmed; Alali, Hamed; Alhathal, Naif; Osman, Yasser; Perovic, Dragoljub; Sajadi, Hesamoddin; Akhavizadegan, Hamed; Vucinic, Miroslav; Kattan, Said; Kattan, Mohamed S.; Mogharabian, Nasser; Phuoc, Nguyen Ho Vinh; Ngoo, Kay Seong; Alkandari, Mohammad H.; Alsuhaibani, Shaheed; Sokolakis, Ioannis; Babaei, Mehdi; King, Mak Siu; Diemer, Thorsten; Gava, Marcelo M.; Henrique, Raphael; Silva, Rodrigo Spinola E.; Paul, Gustavo Marquesine; Mierzwa, Tiago Cesar; Glina, Sidney; Siddiqi, Kashif; Wu, Han; Wurzacher, Jana; Farkouh, Ala'a; Son, Hwancheol; Minhas, Suks; Lee, Joe; Magsanoc, Nikko; Capogrosso, Paolo; Jose Albano, German; Lewis, Sheena E. M.; Jayasena, Channa N.; Alvarez, Juan G.; Teo, Colin; Smith, Ryan P.; Chua, Jo Ben M.; Jensen, Christian Fuglesang S.; Parekattil, Sijo; Finelli, Renata; Durairajanayagam, Damayanthi; Karna, Keshab Kumar; Ahmed, Abdelkareem; Evenson, Don; Umemoto, Yukihiro; Puigvert, Ana; Ceker, Gokhan; Colpi, Giovanni M. (2023). Consensus and Diversity in the Management of Varicocele for Male Infertility: Results of a Global Practice Survey and Comparison with Guidelines and Recommendations, WORLD JOURNAL OF MENS HEALTH. . doi:10.5534/wjmh.220048
  2. Yap, Ning Yi; Ong, Teng Aik; Pailoor, Jayalakshmi; Gobe, Glenda; Rajandram, Retnagowri (2023). The significance of CD14 in clear cell renal cell carcinoma progression and survival prognosis, BIOMARKERS. . doi:10.1080/1354750X.2022.2142292
  3. Chiong, Edmund; Murphy, Declan G.; Buchan, Nicholas C.; Chua, Melvin L. K.; Hakim, Lukman; Hamid, Agus Rizal; Hong, Sung K.; Horvath, Lisa G.; Kanesvaran, Ravi; Khochikar, Makarand; Letran, Jason; Lojanapiwat, Bannakij; Malek, Rohan; Ng, Anthony C. F.; Nguyen Tuan Vinh; Pang, See-Tong; Poon, Darren M. C.; Ong, Teng Aik; Saad, Marniza; Schubach, Kathryn; Shiroki, Ryoichi; Turkeri, Levent; Williams, Scott; Wong, Alvin; Ye, Dingwei; Davis, Ian D. (2022). Managing advanced prostate cancer in the Asia Pacific region: "Real-world" application of Advanced Prostate Cancer Consensus Conference 2019 statements, ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. . doi:10.1111/ajco.13722
  4. Ko, C. H.; Lim, J.; Ng, C. F.; Wei, Y.; Ong, T. A.; Chu, P. S. K.; Chan, W.; Huang, C. Y.; Feng, K. K.; Teoh, J.; Ning, X.; Chiu, P.; Yee, C. H.; Leung, S. (2022). Health-related quality of life of prostate cancer patients on androgen deprivation therapy (ADT), BJU INTERNATIONAL. 129, 6-6
  5. Lim, Jasmine; Sii, Cornilia Ko Siew; Fadzli, Farhana; Fadzli, Ahmad Nazran; Ong, Teng Aik (2022). Evaluation of stone-scoring systems for predicting stone free status and postoperative complications in a multiethnic Asian population, INTERNATIONAL JOURNAL OF UROLOGY. 29, 58-59
  6. Malek, Rohan; Wu, Sheng-Tang; Serrano, Dennis; Tho, Tran; Umbas, Rainy; Teoh, Jeremy; Lojanapiwat, Bannakji; Ong, Teng Aik; On, Weber Kam; Thai, Sam Minh; Kim, Janet; Pophale, Rupesh; Chiong, Edmund (2022). ELIGANT: a Phase 4, interventional, safety study of leuprorelin acetate (ELIGARD (R)) in Asian men with prostate cancer, TRANSLATIONAL ANDROLOGY AND UROLOGY. 11(2), 179-+. doi:10.21037/tau-21-723
  7. Nisheljeet, Singh; Azizi, Abu Bakar; Palaniandy, Kamalanathan; Ganesan, Dharmendra; Ong, Teng Aik; Alias, Azmi; Rajamanickam, Ramalinggam; Atroosh, Wahib M.; Mohd-Zin, Siti Waheeda; Lee-Shamsuddin, Andrea; Nivrenjeet, Singh; Lo, Warren; Abdul-Aziz, Noraishah Mydin (2022). Survey on Untethering of the Spinal Cord and Urological Manifestations among Spina Bifida Patients in Malaysia, CHILDREN-BASEL. 9(7). doi:10.3390/children9071090
  8. San Loh, Pui; Chaw, Sook Hui; Foong, Yi Xian; Ramasamy, Dhurgka; Zaki, Rafdzah Ahmad; Kuppusamy, Shanggar; Ong, Teng Aik; See, Mee Hoong; Khor, Hui Min (2022). Psychological distress among elderly surgical patients who had their surgery postponed during the COVID-19 pandemic, PERIOPERATIVE MEDICINE. 11(1). doi:10.1186/s13741-022-00242-7
  9. Wong, Chris; Wei, Y.; Ong, T. A.; Chu, Peggy; Teoh, Jeremy; Chiu, Peter; Yee, C. H.; Wan, Helen; Leung, Steven; Ng, C. F. (2022). Risks of metabolic diseases and androgen deprivation therapy for prostate cancer in an Asian population: a prospective multi-centre cohort study, BJU INTERNATIONAL. 129, 9-10
  10. Wong, Li Ping; Lai, Lee Lee; See, Mee Hoong; Alias, Haridah; Omar, Sharifah Faridah Syed; Ng, Chong Guan; Ho, Gwo Fuang; Ong, Teng Aik; Wong, Yee Chi; Ooi, Po Lin; Elias, Jasmin Munchar; Hu, Zhijian; Lin, Yulan (2022). Adverse events following immunization and psychological distress among cancer patients/survivors following vaccination against SARS-CoV-2 infection, FRONTIERS IN PSYCHOLOGY. 13. doi:10.3389/fpsyg.2022.906067
Others
  1. Amat, N., Philip, E.F., Chai, C.A., Yeoh, W.S., Lim, J., Fadzli, A.N., Kuppusamy, S. & Ong, T.A. (2021). The impact of population lockdown on the referral pattern for urology in a COVID-19 designated tertiary hospital in Malaysia. Urological Science, 32(1), 23-26.
  2. Chai CA, Yeoh WS, Rajandram R, Aung KP, Ong TA, Kuppusamy S, Nazran A, Kumaran K, Razack AHA, Teoh JY (2021). Comparing CxBladder to Urine Cytology as Adjunct to Cystoscopy in Surveillance of Non-muscle Invasive Bladder Cancer-A Pilot Study. Frontiers of Surgery 8: 659292. doi: 10.3389/fsurg.2021.659292.
  3. Dasgupta R, Ong TA, Lim J, Rajandram R, Gao X, Hakim L, Mburugu P, Ajmera R, Yuruk E, Pu Y-S, Geavlete P, Azhar RA, Mutambirwa S, Baard J (2021). A Global Perspective of Stenting after Ureteroscopy: an Observational Multicenter Cohort Study. Soci t Internationale d'Urologie Journal 2 (2), 96 105
  4. Lim J, Onozawa M, Saad M, Ong TA; A-CaP (Asian Prostate Cancer) Study; J-CaP (Japan Prostate Cancer Study Group); M-CaP (Malaysia Prostate Cancer Study Group), Malek R, Akaza H (2021). Recent trend of androgen deprivation therapy in newly diagnosed prostate cancer patients: Comparing between high- and middle-income Asian countries. Cancer Sci. 112: 2071-2080. doi: 10.1111/cas.14889.
  5. Ngoo, K. S., Fadzli, A.N., Amponin, M.O.C.S.E., Cho, S.Y., Chuang, Y.C., Horiguchi, A., Karthikeyan, V.S., Morshed, M.S., Situmorang, G.R., Tan, T.C., Teoh, J.Y.C., Thaidumrong, T., & Ong, T. A. (2021). COVID 19 pandemic impact on urology residencies in Asia An observational study. Surgical Practice, 25(1), 10-15.
  6. Yap, X. L., Wood, B., Ong, T. A., Lim, J., Goh, B. H., & Lee, W. L. (2021). Detection of Prostate Cancer via IR Spectroscopic Analysis of Urinary Extracellular Vesicles: A Pilot Study. Membranes, 11(8), 591. https://doi.org/10.3390/membranes11080591
  7. Yow, H. Y., Tiong, J., Mai, C. W., van der Werf, E., Zainuddin, Z. M., Toh, C. C., Ngoo, K. S., Goh, E. H., Fadzli, A. N., Lok, S. H., & Ong, T. A. (2021). Prevalence of nocturia among community-dwelling adults: a population-based study in Malaysia. BMC urology, 21(1), 95. https://doi.org/10.1186/s12894-021-00860-1
  8. Jalil, N. B., Lee, P. Y., Nor Afiah, M. Z., Abdullah, K. L., Azizi, F., Rassip, N., Ong, T. A., Ng, C. J., Lee, Y. K., Cheong, A. T., Razack, A. H., Saad, M., Alip, A., Malek, R., Sundram, M., Omar, S., Sathiyananthan, J. R., & Kumar, P. (2020). Effectiveness of Decision Aid in Men with Localized Prostate Cancer: a Multicenter Randomized Controlled Trial at Tertiary Referral Hospitals in an Asia Pacific Country. Journal of cancer education : the official journal of the American Association for Cancer Education, 10.1007/s13187-020-01801-6.
  9. Lim, J., Amantakul, A., Shariff, N., Lojanapiwat, B., Alip, A., Ong, T. A., Thevarajah, S., Ahmayuddin, F., Mathew, A., Sriplakich, S., Vuthiwong, J., Chong, F., & Saad, M. (2020). Clinical outcomes of abiraterone acetate and predictors of its treatment duration in metastatic castration-resistant prostate cancer: Real-world experience in the Southeast Asian cohort. Cancer medicine, 9(13), 4613 4621. https://doi.org/10.1002/cam4.3101
  10. Lim, J., Hinotsu, S., Onozawa, M., Malek, R., Sundram, M., Teh, G. C., Ong, T. A., Thevarajah, S., Zainal, R., Khoo, S. C., Omar, S., Nasuha, N. A., & Akaza, H. (2020). Modified J-CAPRA scoring system in predicting treatment outcomes of metastatic prostate cancer patients undergoing androgen deprivation therapy. Cancer medicine, 9(24), 9346 9352. https://doi.org/10.1002/cam4.3548
  11. Ng, C. J., Teo, C. H., Ang, K. M., Kok, Y. L., Ashraf, K., Leong, H. L., Taher, S. W., Mohd, S. Z., Zakaria, Z. F., Wong, P. F., Hor, C. P., Ong, T. A., Hussain, H., V, P., Ng, C. W., Agamutu, K., & Abd Razak, M. A. (2020). Barriers to implementing a national health screening program for men in Malaysia: An online survey of healthcare providers. Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia, 15(1), 6 14.
  12. Perumal, K., Mun, K. S., Yap, N. Y., Razack, A., Gobe, G. C., Ong, T. A., Kuppusamy, S., & Rajandram, R. (2020). A Study on the Immunohistochemical Expressions of Leptin and Leptin Receptor in Clear Cell Renal Cell Carcinoma. BioMed research international, 2020, 3682086. https://doi.org/10.1155/2020/3682086
  13. Ramasandran, G., Yen, K.S., Mat, S., Kamaruzzaman, S.B., Vyrn, C.A., Aik, O.T., Razack, A.H.A. & Pin, T.M. (2020). Ethnic differences in urinary incontinence among women aged 55 years and over: results from the Malaysian Elders Longitudinal Research (MELOR). Journal of Health and Translational Medicine, 23(1), 18-22.
  14. Teoh, J. Y., Cho, C. L., Wei, Y., Isotani, S., Tiong, H. Y., Ong, T. A., Kijvikai, K., Chu, P. S., Chan, E. S., Ng, C. F., & Asian Urological Surgery Training & Education Group (2020). Surgical training for anatomical endoscopic enucleation of the prostate. Andrologia, 52(8), e13708. https://doi.org/10.1111/and.13708
  15. Yii, R., Lim, J., Sothilingam, S., Yeoh, W. S., Fadzli, A. N., Ong, T. A., Kuppusamy, S., & Abdul Razack, A. H. (2020). Predictive factors of prostate cancer diagnosis with PSA 4.0-10.0 ng/ml in a multi-ethnic Asian population, Malaysia. Asian journal of surgery, 43(1), 87 94. https://doi.org/10.1016/j.asjsur.2019.02.014
  16. de la Rosette, J., Laguna, P., lvarez-Maestro, M., Eto, M., Mochtar, C. A., Albayrak, S., Mendoza-Valdes, A., Ong, T. A., Khadgi, S., Al-Terki, A., Bolton, D., Gomez, R., Klotz, L., Kulkarni, S., Tanguay, S., Gravas, S., & Soci t Internationale d Urologie Board of Directors (2020). Cross-continental comparison of safety and protection measures amongst urologists during COVID-19. International journal of urology : official journal of the Japanese Urological Association, 27(11), 981 989. https://doi.org/10.1111/iju.14340
  17. Aldoghachi, A. F., Baharudin, A., Ahmad, U., Chan, S. C., Ong, T. A., Yunus, R., Razack, A. H., Yusoff, K., & Veerakumarasivam, A. (2019). Evaluation of CERS2 Gene as a Potential Biomarker for Bladder Cancer. Disease markers, 2019, 3875147. https://doi.org/10.1155/2019/3875147
  18. Chiong, E., Murphy, D. G., Akaza, H., Buchan, N. C., Chung, B. H., Kanesvaran, R., Khochikar, M., Letran, J., Lojanapiwat, B., Ng, C. F., Ong, T., Pu, Y. S., Saad, M., Schubach, K., T rkeri, L., Umbas, R., Le Chuyen, V., Williams, S., Ye, D. W., ANZUP Cancer Trials Group, Davis, I. D. (2019). Management of patients with advanced prostate cancer in the Asia Pacific region: 'real-world' consideration of results from the Advanced Prostate Cancer Consensus Conference (APCCC) 2017. BJU international, 123(1), 22 34. https://doi.org/10.1111/bju.14489
  19. Lim, H. C., Khong, T. L., Ong, T. A., Roslani, A. C., & Ang, C. W. (2019). Case report: A rare case of extravesical, extraperitoneal metastasis after transuretheral resection of urothelial carcinoma. Urology case reports, 29, 101017. https://doi.org/10.1016/j.eucr.2019.101017
  20. Lojanapiwat, B., Lee, J. Y., Gang, Z., Kim, C. S., Fai, N. C., Hakim, L., Umbas, R., Ong, T. A., Lim, J., Letran, J. L., Chiong, E., Lee, S. H., T rkeri, L., Murphy, D. G., Moretti, K., Cooperberg, M., Carlile, R., Hinotsu, S., Hirao, Y., Kitamura, T., Horie, S., Onozawa, M., Kitagawa, Y., Namiki, M., Fukagai, T., Miyazaki, J., & Akaza, H. (2019). Report of the third Asian Prostate Cancer study meeting. Prostate international, 7(2), 60 67. https://doi.org/10.1016/j.prnil.2018.06.001
  21. Perumal, K., Huin, W. K., Yap, N. Y., Ong, T. A., Gobe, G. C., & Rajandram, R. (2019). Role of leptin as a biomarker for early detection of renal cell carcinoma? No evidence from a systematic review and meta-analysis. Medical hypotheses, 129, 109239. https://doi.org/10.1016/j.mehy.2019.109239
  22. Saad, M., Alip, A., Lim, J., Abdullah, M. M., Chong, F., Chua, C. B., Ismail, F., Khong, R. K., Lim, C. S., Loh, C. S., Malek, R., Mohd Ghani, K. A., Md Noor, I., Md Yusoff, N. A., Nasuha, N. A., Razack, A., Soo Hoo, H. F., Sundram, M., Tan, H. M., Thiagarajan, M., The, G. C., Voon, P. J., & Ong, T. A. (2019). Management of advanced prostate cancer in a middle-income country: real-world consideration of the Advanced Prostate Cancer Consensus Conference 2017. BJU international, 124(3), 373 382. https://doi.org/10.1111/bju.14807
  23. Teoh, J. Y., Cho, C. L., Wei, Y., Isotani, S., Tiong, H. Y., Ong, T. A., Kijvikai, K., Chu, P. S., Chan, E. S., Ng, C. F., & Asian Urological Surgery Training & Education Group (2019). A newly developed porcine training model for transurethral piecemeal and en bloc resection of bladder tumour. World journal of urology, 37(9), 1879 1887. https://doi.org/10.1007/s00345-018-2602-2
  24. Yap, N. Y., Ong, T. A., Morais, C., Pailoor, J., Gobe, G. C., & Rajandram, R. (2019). Establishment of epithelial and fibroblast cell cultures and cell lines from primary renal cancer nephrectomies. Cell biology international, 43(6), 715 725. https://doi.org/10.1002/cbin.11150
  25. Youl Lee, J., Taniguchi, T., Zhang, K., Ng, C. F., Hakim, L., Umbas, R., Kim, C. S., Chung, B. H., Kim, W. J., Aik Ong, T., Lim, J., & Akaza, H. (2019). Report of the forth Asian Prostate Cancer (A-CaP) study meeting. Japanese journal of clinical oncology, 49(6), 581 586. https://doi.org/10.1093/jjco/hyz053
  26. Zhu, C. Z., Ting, H. N., Ng, K. H., & Ong, T. A. (2019). A review on the accuracy of bladder cancer detection methods. Journal of Cancer, 10(17), 4038 4044. https://doi.org/10.7150/jca.28989
  27. Abd Ghafar, N. K., Alip, A., Ong, T. A., Yap, N. Y., & Saad, M. (2018). Efficacy, safety, and prognostic indicators of first-line sunitinib in patients with metastatic renal cell carcinoma: A single center experience. Journal of cancer research and therapeutics, 14(6), 1303 1311. https://doi.org/10.4103/0973-1482.189247
  28. Dadaev, T., Saunders, E. J., Newcombe, P. J., Anokian, E., Leongamornlert, D. A., Brook, M. N., Cieza-Borrella, C., Mijuskovic, M., Wakerell, S., Olama, A., Schumacher, F. R., Berndt, S. I., Benlloch, S., Ahmed, M., Goh, C., Sheng, X., Zhang, Z., Muir, K., Govindasami, K., Lophatananon, A., Kote-Jarai, Z. (2018). Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants. Nature communications, 9(1), 2256. https://doi.org/10.1038/s41467-018-04109-8
  29. Ho, L. Y., Chu, P. S., Consigliere, D. T., Zainuddin, Z. M., Bolong, D., Chan, C. K., Eng, M., Huynh, D. N., Kochakarn, W., Lapitan, M., Le, D. K., Le, Q. D., Lee, F., Lojanapiwat, B., Nguyen, B. N., Ong, T. A., Reyes, B. J., Santingamkun, A., Tsang, W. C., & Abrams, P. (2018). Symptom prevalence, bother, and treatment satisfaction in men with lower urinary tract symptoms in Southeast Asia: a multinational, cross-sectional survey. World journal of urology, 36(1), 79 86. https://doi.org/10.1007/s00345-017-2097-2
  30. Lim, J., Rampal, S., Razack, A., Malek, R., Sundram, M., Nasuha, N. A., Ooi, C. C., Ong, T. A., & Sothilingam, S. (2018). A Novel Calculator for Estimating Prostate Volume in Daily Urology Services. Urology, 118, 145 151. https://doi.org/10.1016/j.urology.2018.02.055
  31. Ng, K. L., Yap, N. Y., Rajandram, R., Small, D., Pailoor, J., Ong, T. A., Razack, A. H., Wood, S. T., Morais, C., & Gobe, G. C. (2018). Nuclear factor-kappa B subunits and their prognostic cancer-specific survival value in renal cell carcinoma patients. Pathology, 50(5), 511 518. https://doi.org/10.1016/j.pathol.2018.03.003
  32. Yap, N. Y., Khoo, W. T., Perumal, K., Ng, K. A., Rajandram, R., Alip, A., Saad, M., & Ong, T. A. (2018). Practical updates in medical therapy for advanced and metastatic renal cell carcinoma. Urological Science, 29(3), 120-128.
  33. Yee, A., Loh, H. S., Ong, T. A., Ng, C. G., & Sulaiman, A. H. (2018). Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of Bupropion as Treatment for Methadone-Emergent Sexual Dysfunction in Men. American journal of men's health, 12(5), 1705 1718. https://doi.org/10.1177/1557988318784152
  34. Kim, C. S., Lee, J. Y., Chung, B. H., Kim, W. J., Fai, N. C., Hakim, L., Umbas, R., Ong, T. A., Lim, J., Letran, J. L., Chiong, E., Wu, T. L., Lojanapiwat, B., T rkeri, L., Murphy, D. G., Gardiner, R. A., Moretti, K., Cooperberg, M., Carroll, P., Mun, S. K., Hinotsu, S., Hirao, Y., Ozono, S., Horie, S., Onozawa, M., Kitagawa, Y., Kitamura, T., Namiki, M., & Akaza, H. (2017). Report of the Second Asian Prostate Cancer (A-CaP) Study Meeting. Prostate international, 5(3), 95 103. https://doi.org/10.1016/j.prnil.2017.03.006
  35. Lee, P. Y., Ng, C. J., Ong, T. A., Lee, Y. K., Khatijah Lim, A., Cheong, A. T., & Azad Hassan, A. R. (2017). Post-treatment impact and needs of prostate cancer survivors in Malaysia; a qualitative study. Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia, 12(3), 18 24.
  36. Rajandram, R., Yap, N. Y., Ong, T. A., Mun, K. S., Mohamad Wali, H. A., Hasan, M. S., Razack, A., & Ali Mohd, M. (2017). Oral ketamine induced pathological changes of the urinary tract in a rat model. The Malaysian journal of pathology, 39(1), 47 53.
  37. Akaza, H., Hirao, Y., Kim, C. S., Oya, M., Ozono, S., Ye, D., Cooperberg, M., Hinotsu, S., Lee, J. Y., Zhu, G., Namiki, M., Horie, S., Chung, B. H., Chen, C. H., Fai, N. C., Hakim, L., Chiong, E., Letran, J., Umbas, R., Suzuki, K., Nishimura, K., Ong, T. A., Lojanapiwat, B., Wu, T. L., Kim, W. J., Murphy, D., Ogawa, O., Carroll, P., Naito, S., & Tsukamoto, T. (2016). Asia prostate cancer study (A-CaP Study) launch symposium. Prostate international, 4(3), 88 96. https://doi.org/10.1016/j.prnil.2016.03.001
  38. Cheong, A. T., Lee, P. Y., Ng, C. J., Lee, Y. K., Ong, T. A., Abdullah, K. L., & Razack, A. H. A. (2016). Doctors' Approaches to Decision Support in Counseling Patients with Localized Prostate Cancer: An Asian Perspective. Sains Malaysiana, 45(6), 941-947.
  39. Lee, P. Y., Cheong, A. T., Ng, C. J., Lee, Y. K., Abdullah, K. L., Razack, A. H. A., & Ong, T. A. (2016). Supporting patients in making treatment decisions for early prostate cancer: a qualitative study of healthcare professionals views on barriers and challenges in an Asian country. Journal of Men's Health, 12(1), 18-24. https://doi.org/10.31083/jomh.v12i1.21
  40. Mun, P. S., Ting, H. N., Mirhassani, S. M., Ong, T. A., Wong, C. M., Chong, Y. B. (2016). Prediction of chronic kidney disease using urinary dielectric properties and support vector machine. Journal of Microwave Power and Electromagnetic Energy, 50(3), 201-213. https://doi.org/10.1080/08327823.2016.1230927
  41. Rajandram, R., Ong, T. A., Razack, A. H., MacIver, B., Zeidel, M., & Yu, W. (2016). Intact urothelial barrier function in a mouse model of ketamine-induced voiding dysfunction. American journal of physiology. Renal physiology, 310(9), F885 F894. https://doi.org/10.1152/ajprenal.00483.2015
  42. Lee, Y. K., Lee, P. Y., Cheong, A. T., Ng, C. J., Abdullah, K. L., Ong, T. A., & Razack, A. H. (2015). To Share or Not to Share: Malaysian Healthcare Professionals' Views on Localized Prostate Cancer Treatment Decision Making Roles. PloS one, 10(11), e0142812. https://doi.org/10.1371/journal.pone.0142812
  43. Lim, J., Bhoo-Pathy, N., Sothilingam, S., Malek, R., Sundram, M., Tan, G. H., Bahadzor, B., Ong, T. A., Ng, K. L., & Abdul Razack, A. H. (2015). Cardiovascular Risk Factors and Ethnicity Are Independent Factors Associated with Lower Urinary Tract Symptoms. PloS one, 10(6), e0130820. https://doi.org/10.1371/journal.pone.0130820
  44. Mun, P. S., Ting, H. N., Chong, Y. B., & Ong, T. A. (2015). Dielectric properties of glycosuria at 0.2-50 GHz using microwave spectroscopy. Journal of Electromagnetic Waves and Applications, 29(17), 2278-2292. https://doi.org/10.1080/09205071.2015.1072480
  45. Mun, P. S., Ting, H. N., Ong, T. A., Wong, C. M., Ng, K. H., & Chong, Y. B. (2015). A Study of Dielectric Properties of Proteinuria between 0.2 GHz and 50 GHz. PloS one, 10(6), e0130011. https://doi.org/10.1371/journal.pone.0130011
  46. Ong, T. A., Khong, S. Y., Ng, K. L., Ting, J. R., Kamal, N., Yeoh, W. S., Yap, N. Y., & Razack, A. H. (2015). Using the Vibrance Kegel Device With Pelvic Floor Muscle Exercise for Stress Urinary Incontinence: A Randomized Controlled Pilot Study. Urology, 86(3), 487 491. https://doi.org/10.1016/j.urology.2015.06.022
  47. Lim, J., Bhoo-Pathy, N., Sothilingam, S., Malek, R., Sundram, M., Hisham Bahadzor, B., Ong, T. A., Ng, K. L., Sivalingam, S., & Razack, A. H. (2014). Ethnicity is an independent determinant of age-specific PSA level: findings from a multiethnic Asian setting. PloS one, 9(8), e104917. https://doi.org/10.1371/journal.pone.0104917
  48. Lim, N. K., Aik, O. T., Meng, L. L., Htun, T. H., & Razack, A. H. (2014). Superior vena caval syndrome secondary to metastatic renal cell carcinoma. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 24 Suppl 1, S68 S70.
  49. Rajandram, R., Yap, N. Y., Pailoor, J., Razack, A. H., Ng, K. L., Ong, T. A., Morais, C., & Gobe, G. C. (2014). Tumour necrosis factor receptor-associated factor-1 (TRAF-1) expression is increased in renal cell carcinoma patient serum but decreased in cancer tissue compared with normal: potential biomarker significance. Pathology, 46(6), 518 522. https://doi.org/10.1097/PAT.0000000000000145
  50. Ong, T. A., Yaakup, N. A., Sivalingam, S., & Razack, A. H. (2013). Hook wire localization for testis sparing surgery. Urology, 81(4), 904 907. https://doi.org/10.1016/j.urology.2012.10.077
  51. Yap, N. Y., Ng, K. L., Ong, T. A., Pailoor, J., Gobe, G. C., Ooi, C. C., Razack, A. H., Dublin, N., Morais, C., & Rajandram, R. (2013). Clinical prognostic factors and survival outcome in renal cell carcinoma patients--a malaysian single centre perspective. Asian Pacific journal of cancer prevention : APJCP, 14(12), 7497 7500. https://doi.org/10.7314/apjcp.2013.14.12.7497
  52. Loh, K. W., Vriens, M. R., Gerritsen, A., Borel Rinkes, I. H., van Hillegersberg, R., Schippers, C., Steenhagen, E., Ong, T. A., Moy, F. M., & Molenaar, I. Q. (2012). Unintentional weight loss is the most important indicator of malnutrition among surgical cancer patients. The Netherlands journal of medicine, 70(8), 365 369.
  53. Ng, K. L., Htun, T. H., Dublin, N., Ong, T. A., & Razack, A. H. (2012). Assessment and clinical significance of haematuria in Malaysian patients - relevance to early cancer diagnosis. Asian Pacific journal of cancer prevention : APJCP, 13(6), 2515 2518. https://doi.org/10.7314/apjcp.2012.13.6.2515
  54. Lee, P., Ong, T., & Dayangku Norlida, A. (2010). Tuberculous prostatic abscess in an immunocompromised patient. Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia, 5(3), 145 147.
  55. Lee, P., Ong, T., Muna, S., Syed Alwi, S., & Kamarudin, K. (2010). Brief report do university students have high cardiovascular risk? A pilot study from Universiti Malaysia Sarawak (UNIMAS). Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia, 5(1), 41 43.
  56. Ong, T. A., Winkler, M. H., Savage, P. M., Seckl, M. J., & Christmas, T. J. (2008). Retroperitoneal lymph node dissection after chemotherapy in patients with elevated tumour markers: indications, histopathology and outcome. BJU international, 102(2), 198 202. https://doi.org/10.1111/j.1464-410X.2008.07533.x
  57. Wong, J. S., Ong, T. A., Chua, H. H., & Tan, C. (2007). Acute anuric renal failure following jering bean ingestion. Asian journal of surgery, 30(1), 80 81. https://doi.org/10.1016/S1015-9584(09)60134-2
  58. McNicholas, T., & Ong, T. (2006). Review of Testim gel. Expert opinion on pharmacotherapy, 7(4), 477 484. https://doi.org/10.1517/14656566.7.4.477
  59. Ong, T. A., & Yip, C. H. (2003). Short-term survival in breast cancer: the experience of the University of Malaya Medical Centre. Asian journal of surgery, 26(3), 169 175. https://doi.org/10.1016/S1015-9584(09)60378-X
  60. Ong, T. A., Peh, S. C., Goh, K. S., Naicker, M. S., Khan, A. F., Chua, B. C., & Razack, A. (2003). P53 protein expression in transitional cell carcinoma of the bladder - experience of the University of Malaya Medical Centre. Asian journal of surgery, 26(1), 31 36. https://doi.org/10.1016/S1015-9584(09)60212-8
Chapter in Books
  1. Rajandram, R., Ong, T. A., & Saad, M. (2014). Resistance of renal cell carcinoma to targeted therapy. Advances in Drug Resistance Research. New York: Nova Science Publishers, 203-24.

RESEARCH INTEREST

  • Illicit ketamine related cystitis and its reversibility. (Ketamine, abuse, cystitis)
  • A prospective, randomized, double-blind, placebo- controlled, parallel-group, multicenter study of the efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase-5 inhibitor (premature ejaculation, erectile dysfunction, dapoxetine)
  • Axitinib for the treatment of metastatic renal cell cancer (renal cell carcinoma, metastasis, axitinib)

RESEARCH PROJECT

National
  1. 2020 - 2024, Fundamental Research Grant Scheme (FRGS)
    Construing The Roles Of Adipokines And Their Mechanism In Renal Cell Carcinoma (rcc) ( Co-Researcher)
  2. 2019 - 2023, Fundamental Research Grant Scheme (FRGS)
    Deciphering Survival Strategies Of Uropathogenic Escherichia Coli (upec)in Establishing Urinary Tract Infections ( Co-Researcher)
  3. 2020 - 2023, RU Geran - Fakulti Program
    Clinical And Molecular Investigation On The Role Of Cholesterol In Improving Drug Response In Bladder Cancer ( Co-Researcher)
  4. 2019 - 2022, Others MOHE - Top 100 (IIRG)-HWB
    Characterization Of Farnesyl Diphosphate Farnesyltransferase 1 (fdft1) Expression In Cisplatin -treated Muscle -invasive Bladder Cancer ( Co-Researcher)
  5. 2017 - 2020, Geran Penyelidikan Universiti Malaya (UMRG) - AFR (Frontier Science)
    Molecular profiling and pathway analysis of clinically aggressive Renal Cell Carcinoma ( Co-Researcher)
  6. 2014 - 2019, Grand Challenge - HTM (Wellness)
    Lower Urinary Tract Symptoms And Sexual Dysfunction Among Patients With Osteoarthritis ( Co-Researcher)
  7. 2016 - 2019, Fundamental Research Grant Scheme (FRGS)
    Establishing The Roles Of The Receptors Involved In The Purinergic Signalling Pathway In The Human Bladder ( Principal Investigator(PI))
  8. 2017 - 2019, Fundamental Research Grant Scheme (FRGS)
    Establishing the role of histone H3 lysine 27(H3K27) demethylases in renal cell carcinoma and bladder cancers invasiveness and progression ( Co-Researcher)
  9. 2016 - 2017, Postgraduate Research Grant (PPP) - Course & Disertation
    Linguistic Translation and Validation of Nocturia Quality of Life (N-QOL) questionnaire ( Principal Investigator(PI))
  10. 2013 - 2016, Geran Penyelidikan Universiti Malaya (UMRG) - HTM (Wellness)
    Traf1 And Nf-kb : Understanding And Evaluating The Molecular Mechanisms And Therapeutic Potential In Renal Cell Carcinoma ( Principal Investigator(PI))
  11. 2013 - 2016, Fundamental Research Grant Scheme (FRGS)
    Deciphering The Molecular Mechanisms And Therapeutic Potential Of Traf1 And Nf-kb In Renal Cell Carcinoma ( Principal Investigator(PI))
  12. 2014 - 2016, Geran Penyelidikan Universiti Malaya (UMRG) - AFR (Frontier Science)
    Evaluation Of Urokinase Plasminogen Activator Receptor, Cytokines And Chemokines In Kidney Stone Diseases Pre And Post-percutaneous Nephrolithotomy (pcnl) ( Co-Researcher)
  13. 2012 - 2015, Geran Penyelidikan Universiti Malaya (UMRG) - HTM (Wellness)
    Urinary Tract And Liver Injury From Long Term Oral Ketamine And Its Reversibility In A Rat Model. ( Principal Investigator(PI))
  14. 2014 - 2015, RU Geran
    The Mechanism Of Ketamine Cystitis In A Rat Model ( Principal Investigator(PI))
  15. 2012 - 2014, High Impact Research - University of Malaya (HIR-UM)
    Large-scale Profiling of Cancer/Testis Antigens (CTA) and the Delineation of MiRNA-mediated Reversal of CTA-associated Aberrant Demethylation in Urothelial Cell Carcinoma. ( Principal Investigator(PI))
  16. 2010 - 2011, Geran Penyelidikan Universiti Malaya (UMRG)
    ILLICIT KETAMIN RELATED CYSTITIS AND ITS REVERSIBILITY ( Principal Investigator(PI))
  17. 2012 - 2015, Janssen Cilag (Johnson & Johnson)
    ABI-PRO 3002 : A phase 3, randomized, double-blind, placebo-controlled study of abiraterone acetate (JNJ-212082) plus prednisone in asymptomic or mildly symptomatic patients with metastatic castration-resistant prostate cancer. ( Consultant)
  18. 2012 - 2014, High Impact Research (HIR)
    Large-scale profiling of Cancer/Testis Antigens (CTA) and the delineation of MiRNA-mediated reversal of CTA-associated aberrant demethylation in urothelial cell carcinoma ( Principal Investigator(PI))
  19. 2012 - 2014, UPM Research University Grant Scheme, RUGS
    Developing and pilot-testing an intervention decision aid for patients with prostate cancer who are making decision about prostate cancer treatment ( Consultant)
  20. 2011 - 2013, Janssen Cilag
    An Open Label Study of Abiraterone Acetate in Subjects with Metastatic Castration-Resistant Prostate Cancer Who Have Progressed After Taxane-Based Chemotherapy ( Consultant)
  21. 2012 - 2013, Geran Penyelidikan Universiti Malaya (UMRG)
    Urinary tract and liver injury from long term oral ketamine ( Principal Investigator(PI))
  22. 2011 - 2012, Geran Penyelidikan Universiti Malaya (UMRG)
    Caspase-8 and TRAF1 as biomarkers of progression of Renal Cell Carcinomas ( Consultant)
International
  1. 2020 - 2022, International Funding
    Analysis of The Cell Growth and Protein Secretion Capacity of Foreskin, Bladder and Ureter Cells With The Final Aim To Improve Medical Device Biocompatibility ( Co-Researcher)
  2. 2015 - 2020, Industry
    KEYNOTE-052 : A Phase 2 Clinical Trial of Pembrolizumab in Subjects with advanced/ unresectable or metastatic urothelial cancer. ( Consultant)
  3. 2012 - 2018, Janssen Cilag
    LATITUDE : A randomised double-blind comparative study of Zytiga (abiraterone acetate) plus low dose prednisolone plus androgen deprivation therapy (ADT) versus ADT alone in newly diagnosed subjects with high risk metastatic hormone-naive prostate cancer (mHNPC). LATITUDE ( Consultant)
  4. 2013 - 2018, Medivation and Astella
    PROSPER A multinational, Phase 3, Randomized, Double blinde, Placebo controlled, Efficacy and Safety of Enzalutamide in Patient With Nonmetastatic Castration-Resistant Prostate Canncer ( Consultant)
  5. 2016 - 2017, International Funding
    A phase III, multicentre, randomised, double blind, parallel group, placebo controlled study to assess the efficacy and safety of one or more intradetrusor treatment of 600 or 800 units of Dysport for the treatment of urinary incontinence in subjects with neurogenic detrusor overactivity due to spina cord injury or multiple sclerosis ( Consultant)
  6. 2011 - 2012, Sanofi-Aventis
    Multicentre, single-arm, open label, clinical trial intended to provide early access to cabazitaxel in patients with metastatic hormone refractory prostate cancer previously treated with a docetaxel-containing regimen and to document safety of cabazitaxel in these patients. ( Consultant)
  7. 2010 - 2011, Johnson & Johnson
    A prospective, randomized, double-blind, placebo- controlled, parallel-group, multicenter study of the efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase-5 inhibitor: COUPLE: COncomitant Use of PriLigy in Men Treated for Erectile Dysfunction ( Consultant)
  8. 2010 - 2011, Pfizer
    AG-013736 (Axitinib) for the treatment of metastatic renal cell cancer. ( Consultant)

CONSULTANCY PROJECT

  • Committee for Subspecialty Training for Urology, Ministry of Health, Malaysia, Kementerian Kesihatan Malaysia
    01 Nov 2020 - 01 Nov 2022 (National)

PAPER PRESENTED

PLENARY SPEAKER
  1. Treat One or Treat Both -ED & BPH/LUTS, Men s Health World Congress scheduled, Malaysian Society of Andrology and the Study of Ageing Males (MSASAM) and the Malaysian Clearinghouse for Men s Health (International) (11 Dec 2023 - 13 Dec 2023)
  2. GnRH agonist in Prostate Cancer, Malaysian Urological Conference, Malaysian Urological Association (National) (23 Nov 2023 - 25 Nov 2023)
  3. A-PCa data 2023: Focus on ASEAN, South East Asia Urological Conference, Tann Anh General Hospital Ho Chi Minh City, Vietnam (International) (07 Sep 2023 - 09 Sep 2023)
  4. Urinary continence post radical prostatectomy, South East Asia Urological Conference, Tann Anh General Hospital, Ho Chi Minh City, Vietnam (International) (07 Sep 2023 - 09 Sep 2023)
  5. Is there an ideal urinary marker for urothelial cancer?, 2023 Annual Meeting of Taiwan Urological Association, Taiwan Urological Association (International) (19 Aug 2023 - 20 Aug 2023)
  6. Current status of postoperative urinary incontinence after prostate cancer in Malaysia, 8th Chinese Urological Control Pelvic Floor Disease Summit, The National Centre for Geriatric Medicine and the Department of Urology of Beijing Hospital (International) (27 May 2023 - 27 May 2023)
  7. Early Detection and Management Of Localised Prostate Cancer, Sabah Urology Update, Malaysian Urological Association (National) (19 May 2023 - 20 May 2023)
  8. The challenge of prostate cancer screening in an Asian country, 110th JUA Annual Conference, Japan Urological Association (International) (20 Apr 2023 - 23 Apr 2023)
  9. Should we screen for Prostate Cancer in Asia?, Annual Conference of the Urological Society of India - USICON 2023, Urological Society of India (International) (02 Feb 2023 - 05 Feb 2023)
  10. Working towards an ideal prostate biopsy approach in Asia, 17th BAUSCON 2023 (International Scientific Conference), Bangladesh Association of Urological Surgeons (International) (08 Jan 2023 - 09 Jan 2023)
  11. Systemic therapy for prostate cancer, UAA 2022 Congress, Urological Association of Asia (International) (05 Oct 2022 - 08 Oct 2022)
  12. Cytoreductive nephrectomy: new rules of engagement?, SUA Urofair, Singapore Urological Association (International) (14 Jul 2022 - 16 Jul 2022)
  13. Update of neoadjuvant vs adjuvant treatment of upper urinary tract TCC, 33th Annual Meeting of the Thai Urological Association under the Royal Patronage, Thai Urological Association under the Royal Patronage (International) (05 May 2022 - 07 May 2022)
  14. Update management in N+, M0 prostate cancer, The 13th Uro-Oncology Update, Cipto Mangunkusumo National Referral Hospital (International) (12 Feb 2022 - 13 Feb 2022)
  15. Urothelial Carcinoma: Latest therapeutic advancement, Taiwan Urological Oncology Association Annual Scientific meeting, Taiwan Urological Oncology Association, TUOA (International) (07 Jan 2017 - 07 Jan 2017)
  16. Current update on Overactive Bladder in 2016, 25th Malaysian Urological Conference, Malaysian Urological Association (National) (25 Nov 2016 - 27 Nov 2016)
  17. Treatment of BPH 80 gram TUR-P, Prostate enucleation, Laser prostatectomy, open prostatectomy, 27th World Congress on Videourology & Advances in Clinical Urology, Endourological Society (International) (09 Jun 2016 - 11 Jun 2016)
  18. What's the latest evidence with use of enzalutamide and abiraterone, and in what directions are they heading, Asian Prostate Cancer Forum (APCF) 2016, Ferring (International) (02 Apr 2016 - 02 Apr 2016)
  19. ADT and cardiovascular risk: Asian experiences, Asian Prostate Cancer Forum (APCF) 2016, Ferring (International) (02 Apr 2016 - 02 Apr 2016)
  20. Update on Female Tapes: When, Which and How, 23rd Malaysian Urological Conference 2014, Malaysian Urological Association (National) (21 Nov 2014 - 23 Nov 2014)
INVITED SEMINAR
  1. Common Prostate Disorders, Public Talk on Prostate Disorders, Sinchew Daily (National) (10 Dec 2016 - 10 Dec 2016)
  2. Urinary stone disease, Sinchew online video portal, Sinchew Daily Headquarter (National) (10 Nov 2016 - 10 Nov 2016)
INVITED SPEAKER
  1. Updates on Overactive Bladder (OAB), Men s Health World Congress, Malaysian Society of Andrology and the Study of Ageing Males (MSASAM) and the Malaysian Clearinghouse for Men s Health (International) (11 Dec 2023 - 13 Dec 2023)
  2. Prostatic Urethral Stent Its Utility in Modern MIST Era, Malaysian Urological Conference, Malaysian Urological Association (National) (23 Nov 2023 - 25 Nov 2023)
  3. Challenges in Urolithiasis: Choosing the Best Intervention for Urinary Stones, 43rd Congress of the Soci t Internationale d'Urologie (SIU), Soci t Internationale d'Urologie (SIU) (International) (11 Oct 2023 - 14 Oct 2023)
  4. Controversies in the role of ureteroscopy for UTUC, SIU Istanbul 2023, SIU (International) (11 Oct 2023 - 14 Oct 2023)
  5. Prostate cancer: Navigating the path forward, Virtual Urological Webinar, Unit of Urology, Department of Surgery, Faculty of Medicine, Universiti Malaya (National) (05 Aug 2023 - 06 Aug 2023)
  6. Nocturia due to Nocturnal Polyuria: Why reducing wee frequency in the wee hours matters to your patients, PMPASKL Annual Scientific Congress 2023, Private Medical Practitioners' Association of Selangor & Kuala Lumpur (National) (22 Jul 2023 - 23 Jul 2023)
  7. Prostate cancer screening in Asia, HKUA-EAU Joint Symposium, Hong Kong Urological Association (International) (24 Jun 2023 - 24 Jun 2023)
  8. An innovative Surgeon, Master of Surgery New Intake Orientation, Department of Surgery , Faculty of Medicine, Universiti Malaya (University) (06 Jun 2023 - 06 Jun 2023)
  9. Use of Enzalutamide in Prostate Cancer, Sabah Urology Update, Malaysian Urological Association (National) (19 May 2023 - 20 May 2023)
  10. Current landscape of immunotherapy in non-muscle invasive BC, SURF, Malaysian Urological Association & Malaysian Oncological Society (National) (04 Mar 2023 - 05 Mar 2023)
  11. A New Horizon for Locally Advanced or Metastatic Urothelial Carcinoma, SURF, Malaysian Urological Association & Malayisian Oncological Society (National) (04 Mar 2023 - 05 Mar 2023)
  12. ADT in Advanced Prostate Cancer What s New for Malaysia Patients, Round table discussion on prostate cancer, Ferring (National) (24 Jan 2017 - 24 Jan 2017)
  13. Principles of radical and partial nephrectomy, AUSTEG Laparoscopic Upper Tract Surgery Course, Asian Urological Surgery Training and Education Group (AUSTEG) (International) (14 Jan 2017 - 15 Jan 2017)
  14. Case Studies Troubleshooting and management, AUSTEG Laparoscopic Upper Tract Surgery Course, Asian Urological Surgery Training and Education Group (AUSTEG) (International) (14 Jan 2017 - 15 Jan 2017)
  15. Managing common prostate problems in primary care, Teaching session for Master of Family Medicine, Department of Family Medicine, Faculty of Medicine, University of Malaya (University) (10 Jan 2017 - 10 Jan 2017)
  16. Surgical Management of Prostate Cancer, Prostate Pathology Assessment Seminar-Workshop, Department of Pathology, Faculty of Medicine, University of Malaya (National) (17 Nov 2016 - 17 Nov 2016)
  17. What is BPH? Men's walnut problem, Health in the City 2016 (HITC 2016) public forum, MIMS Medica (National) (13 Nov 2016 - 13 Nov 2016)
  18. Introduction to laparoscopic urologic operations, AUSTEG Urology Nursing Workshop, Asian Urological Surgery Training and Education Group (International) (05 Nov 2016 - 05 Nov 2016)
  19. Laparoscopic pyeloplasty- the current trend and status, 3rd "Golden Bridge" International Urology Conference, Kunming Medical University (International) (28 Oct 2016 - 30 Oct 2016)
  20. Practical Approach to BPH, Malaysian Pharmacy Society CME, Eli Lilly (National) (23 Oct 2016 - 23 Oct 2016)
  21. ED & BPH Two problems. One Solution, Malaysian Pharmacy Society CME, Eli Lilly (National) (23 Oct 2016 - 23 Oct 2016)
  22. Urology Masterclass, Urology Masterclass, Eli Lilly (National) (22 Oct 2016 - 22 Oct 2016)
  23. Case Study Sharing- Prostate Cancer, Xtandi Expert Meeting, Astellas (National) (23 Sep 2016 - 23 Sep 2016)
  24. The role of PSA testing, Melody FM Health Section, Melody FM (National) (19 Sep 2016 - 19 Sep 2016)
  25. EAU guidelines updates, Art of Oncology 2016, Sanofi (National) (17 Sep 2016 - 17 Sep 2016)
  26. Present status of the registration for the A-CaP in each country: Malaysia, 2nd A-Cap (Asia Pacific Prostate Cancer Registry) Meeting, A-Cap Prostate Cancer Registry (International) (08 Sep 2016 - 08 Sep 2016)
  27. Key Publications in Uro-oncology 1 (kidney/bladder), MBU/FRCS(Urol) viva preparatory course, UKM (National) (03 Sep 2016 - 04 Sep 2016)
  28. Sexual Dysfunction And Continence, Elderly living with OSTEOARTHRITIS: Promoting Independent and Quality Of Life, The Grand Challenge PISA group and the Ageing and Age Associated Disorder Research Group, University of Malaya (National) (29 Aug 2016 - 29 Aug 2016)
  29. Men's Sexual Health, Adult Sexual Health Workshop, AiFM (National) (27 Aug 2016 - 27 Aug 2016)
  30. Debate: LHRH against vs antagonists in Prostate Cancer, 3i Pathways Workshop, Majestic Hotel, Kuala Lumpur (National) (13 Aug 2016 - 13 Aug 2016)
  31. Common Prostate Disorders, Public Talk on Prostate Disorders, Sinchew Daily (National) (30 Jul 2016 - 30 Jul 2016)
  32. Sequential agents for CRPC - high costs, low yield?, 14th UAA Congress 2016, Urological Association of Asia, UAA (International) (20 Jul 2016 - 24 Jul 2016)
  33. Benign Prostatic Hyperplasia, Cialis BPH Training and DKSH Field Force, Eli Lilly (National) (12 Jul 2016 - 12 Jul 2016)
  34. Management of advanced prostate cancer, Prostate Cancer Training, Ferring (National) (28 Jun 2016 - 28 Jun 2016)
  35. Effectiveness of Cialis once a day, Urology Masterclass, Eli Lilly (University) (20 May 2016 - 20 May 2016)
  36. Case Sharing and Discussion 2: A Challenging Case of mCRPC, Focus Group Discussion: Treatment Sequencing in mCRPC, Johnson & Johnson (National) (29 Apr 2016 - 29 Apr 2016)
  37. Practical approach for patient with Nocturia, Sarawak Urology Update, Malaysian Urological Association (National) (23 Apr 2016 - 23 Apr 2016)
  38. Hypogonadism and Men's Health, Sarawak Urology Update, Malaysian Urological Association (National) (23 Apr 2016 - 23 Apr 2016)
  39. Erectile Dysfunction: More Than Meets The Eye, Vitacare Staff Training, Vitacare (National) (13 Apr 2016 - 13 Apr 2016)
  40. Laparoscopic nephrectomy, 5TH Urology Laparoscopic Workshop, UKM (National) (11 Apr 2016 - 12 Apr 2016)
  41. Effectiveness of Cialis Once a Day, Urology Masterclass, Eli Lilly (National) (30 Mar 2016 - 30 Mar 2016)
  42. Urinary tract infection, Men s Health Academy, Pfizer (National) (26 Mar 2016 - 26 Mar 2016)
  43. Incontinence in Male Older Adult and Benign Prostate Hyperplasia, Geriatric Training Day, Incontinence in Elderly, Unit of Geriatrics, Department of Medicine, Faculty of Medicine, University of Malaya (University) (23 Mar 2016 - 23 Mar 2016)
  44. Nocturia, Malaysian Enterostomal Therapy Nursing Education Program (Malaysian ETNEP), Enterostomal Therapy Team, University Malaya Medical Centre, Kuala Lumpur (International) (09 Mar 2016 - 09 Mar 2016)
  45. Kidney stone- an overview, NTV7 Health Talk Show, NTV7 (National) (08 Mar 2016 - 08 Mar 2016)
  46. Urostoma, Malaysian Enterostomal Therapy Nursing Education Program (Malaysian ETNEP), Enterostomal Therapy Team, University Malaya Medical Centre, Kuala Lumpur (International) (02 Mar 2016 - 02 Mar 2016)
  47. Prostate Cancer Update and Disease Training, Sanofi Staff Training Session, Sanofi (National) (21 Jan 2016 - 21 Jan 2016)
  48. Prostate Cancer Case Sharing, ESOU- Ipsen South Asia Symposium, Ipsen (International) (17 Jan 2016 - 17 Jan 2016)
  49. One man two problems , one solution, Primay Care Workshop, MALAYSIAN MEDICAL ASSOCIATION, MELAKA BRANCH (National) (04 Oct 2015 - 04 Oct 2015)
  50. Daily dosing for ED- what s the rationale?, Primary Care Workshop, MALAYSIAN MEDICAL ASSOCIATION, MELAKA BRANCH (National) (04 Oct 2015 - 04 Oct 2015)
  51. Managing ED for Prostate Cancer Survivors, Prostate Cancer Talk, Prostate Cancer Support Group (National) (27 Sep 2015 - 27 Sep 2015)
  52. Importance of Multidisciplinary team approach in the management of prostate cancer, Art of Oncology, Sanofi-Aventis Malaysia (National) (06 Dec 2014 - 06 Dec 2014)
  53. Nocturia: Time to Wake Up, Urology Frontier, Ferring (International) (30 Nov 2014 - 30 Nov 2014)
  54. Update on Female Tapes: When, Which and How, 23rd Malaysian Urological Conference, Malaysia Urological Association, MUA (National) (23 Nov 2014 - 23 Nov 2014)
  55. Research in Urology (selected highlights): Ketamine bladder: What have we learned from animal studies?, 34th Congress of the Societe Internationale D'Urologie, Societe Internationale D'Urologie (International) (12 Oct 2014 - 15 Oct 2014)
  56. Imaging of Cancers in Urology, Annual Scientific Meeting of the College of Surgeons, Academy of Medicine Malaysia, College of Surgeons, Academy of Medicine Malaysia (National) (23 May 2014 - 25 May 2014)
  57. Management of Early Prostate Cancer, WONCA Asia Pacific Regional Conference 2014, The Academy of Family Physicians of Malaysia (International) (22 May 2014 - 24 May 2014)
  58. Micturition: Anatomy and Physiology, Contemporary Management of Incontinence (CMI) Course 2013 , Continence Unit, UMMC (National) (25 Sep 2013 - 25 Sep 2013)
  59. Extending the duration,Expanding the horizon the Tadalafil way, MIMSCPD Workshop on Urology, MIMSCPD (National) (22 Sep 2013 - 22 Sep 2013)
  60. ED, CVD and Diabetes: What s the Link? , Pharmacy in Health Transformation Seminar, Malaysian Pharmaceutical Society (National) (20 Sep 2013 - 20 Sep 2013)
  61. What is the role of PDE5-inhibitors on penile rehabilitation post-prostatectomy (TURP/TVP), Asia Urology Scientific Forum, Lilly (International) (29 Jun 2013 - 29 Jun 2013)
  62. Urology Surgery, 20TH NATIONAL PERIOPERATIVE NURSING SEMINAR 2013 , MNA Perioperative Special Interest Group (National) (25 Jun 2013 - 25 Jun 2013)
  63. ED, cardiovascular risk and diabetes : Why early diagnosis is important?, PHAME Multidisciplinary Workshop for Pharmacists, Pfizer (National) (19 May 2013 - 19 May 2013)
  64. Management Pathway for PCa Patients with Bone Mets (In Malaysia), GSK Asia Pacific Advisory Board: Prostate Cancer Patients with Bone Metastases, GSK Service Unlimited (International) (18 May 2013 - 18 May 2013)
  65. Challenges in the treatment of urinary tract infection, 1st MMA-MIMS CPD National Scientific Conference, MIMS CPD (National) (15 Mar 2013 - 15 Mar 2013)
  66. Integration of the role of urologists and oncologists in the treatment of urological cancers. , MOS-MUA collaboration scientific meeting (RCC), GSK (National) (18 Dec 2010 - 18 Dec 2010)
  67. Guideline and practice of lower urinary tract symptoms treatment in Malaysia, ASEAN LUTS expert meeting, Astella, Japan. (International) (27 Nov 2010 - 27 Nov 2010)
  68. Vesicovaginal and ureterovaginal fistulae and Nocturia , Continence Seminar , Malaysian Continence Foundation (National) (13 Oct 2010 - 15 Oct 2010)
  69. Erectile dysfunction , Erectile dysfunction , Bayer (Others) (22 Aug 2010 - 22 Aug 2010)
  70. Management of Iatrogenic Ureteric Injuries & How to Avoid Them, College of Surgeons AGM and Annual Scientific Meeting, College of Surgeons (National) (29 May 2010 - 29 May 2010)
  71. PRIMED GP Workshop on Premature Ejaculation (on dapoxetine), GP Workshop , Faculty of Medicine, University Malaysia Sarawak, Kuching (National) (02 May 2010 - 02 May 2010)
  72. Evaluation of patients presented with LUTS and OAB- practical management plan, Evaluation of patients presented with LUTS and OAB- practical management plan, GSK (National) (27 Apr 2010 - 27 Apr 2010)
  73. Evaluation of patients presented with LUTS and OAB- practical management plan, Office Urology- Focus on BPH and OAB- Family Physician Perspective, GSK (National) (28 Mar 2010 - 28 Mar 2010)
EVENT ORGANISER
  1. 23rd Malaysian Urological Conference 2014, 23rd Malaysian Urological Conference 2014, Malaysian Urological Association (National) (21 Nov 2014 - 23 Nov 2014)
ORAL PRESENTER
  1. Urokinase and its receptor expression in patients undergone percutaneous nephrolithotomy TA Ong,R Rajandram,Lucy Chan,Azad Hassan Razack,Puspha Jayasihman,Hemalatha.S, 25th Malaysian Urological Association Conference Humanising Technology in Urology,, Malaysian Urological Association (International) (25 Nov 2016 - 27 Nov 2016)
POSTER PRESENTER
  1. TA Ong, R Rajandram,Lucy Chan,Azad Hassan Razack,Puspha Jayasihman,Hemalatha.The expression of inflammatory cytokines cases of percutaneous nephrolithotomy., 25th Malaysian Urological Association Conference Humanising Technology in Urology, Malaysian Urological Association (International) (25 Nov 2016 - 27 Nov 2016)
  2. PATHOLOGICAL CHANGES OF THE URINARY TRACT FROM ORAL KETAMINE AND ITS REVERSIBILITY IN A RAT MODEL., USANZ (Urological Society of Australia and New Zealand), Urological Society of Australia and New Zealand (International) (17 Mar 2014 - 19 Mar 2014)
PRESENTER
  1. Impact and Needs of Prostate Cancer Survivors in a Country with Low Incidence of Prostate Cancer, PCWC 2015 (Prostate Cancer World Congress), PCWC 2015 Congress Organisers (International) (17 Aug 2015 - 21 Aug 2015)
  2. Viva on BPH management in the elderly, Advanced Urology Workshop on BPH, College of Surgeons, Academy of Medicine, and Malaysian Urological Association (National) (22 May 2014 - 22 May 2014)
OTHERS
  1. Semi-live surgery 2, Urology Symposium 2016, Division of Urology, Department of Surgery, Chinese University of Hong Kong (International) (04 Nov 2016 - 05 Nov 2016)
  2. Session XII: Prostate Cancer, Asia Pacific Prostate Society (APPS) Conference, APPS (International) (09 Sep 2016 - 10 Sep 2016)
  3. Present status of the registration for the A-CaP in each country, 2nd A-Cap (Asia Pacific Prostate Cancer Registry) Meeting, A-Cap Prostate Cancer Registry (International) (08 Sep 2016 - 08 Sep 2016)
  4. Expert video session: Multi-energy in prostate surgery, 27th World Congress on Videourology & Advances in Clinical Urology, Endourological Society (International) (09 Jun 2016 - 11 Jun 2016)
  5. Conventional androgen deprivation therapy and its safety, Asian Prostate Cancer Forum (APCF) 2016, Ferring (International) (02 Apr 2016 - 02 Apr 2016)
  6. UKMMC ASEAN Laparoscopic Reconstructive Urology Workshop, UKMMC ASEAN Laparoscopic Reconstructive Urology Workshop, UKMMC (International) (24 Aug 2015 - 25 Aug 2015)
  7. Cairns Consensus Statement: Management of Advanced Prostate Cancer in Asia Pacific, Cairns Consensus Statement: Management of Advanced Prostate Cancer in Asia Pacific, A/Prof Dr Declan Murphy, PeterMc Hospital, Melbourne, Australia (International) (16 Aug 2015 - 16 Aug 2015)
  8. Chemotherapy in mCRPC, Lecture on Chemotherapy in mCRPC , Sanofi-Aventis Malaysia (National) (18 Dec 2014 - 18 Dec 2014)
  9. ISI Workshop for Academic Staff, ISI Workshop for Academic Staff, UM Library (University) (11 Dec 2014 - 11 Dec 2014)
  10. Erectile Dysfunction- Opportunities in the difficult treatment groups, 23rd Malaysian Urological Conference, Malaysia Urological Association (National) (22 Nov 2014 - 22 Nov 2014)
  11. Plenary 5 Prostate Cancer Discussion, 23rd Malaysian Urological Conference, Malaysia Urological Conference (National) (21 Nov 2014 - 21 Nov 2014)
  12. Prostate MR Imaging & Biopsy Masterclass, Prostate MR Imaging & Biopsy Masterclass, 15th Asia-Pacific Prostate Cancer Conference 2014 (International) (31 Aug 2014 - 31 Aug 2014)
  13. ERBE workshop, Urology Workshop, Storz (National) (09 Jun 2014 - 10 Jun 2014)
  14. Asia Pacific Prostate Cancer Preceptorship Program, Asia Pacific Prostate Cancer Preceptorship Program, Charite Hospital, Berlin, Germany (International) (13 May 2014 - 15 May 2014)
  15. Ca Prostate - Diagnosis and staging, Risk stratification and nomograms., Advanced Urology Course: Prostate Cancer, Malaysian Urological Association (National) (31 Aug 2013 - 01 Sep 2013)
  16. Choosing between different LHRH for locally advanced and metastatic prostate cancer & How 3i pathways help clinicians in patient management, Prostate cancer symposium, Menarini (National) (06 Jun 2013 - 06 Jun 2013)
  17. Meet-the-expert: Iatrogenic Ureteric Injuries- Immediate Management, Annual General Meeting & Annual Scientific Meeting, The College of Surgeons, Academy of Medicine of Malaysia, The College of Surgeons, Academy of Medicine of Malaysia (National) (31 May 2013 - 02 Jun 2013)
  18. Overcoming Prostate Cancer: New Approaches to an Old Problem, Urofair, Singapore, Singapore Urological Association (International) (08 Mar 2013 - 08 Mar 2013)
  19. Video Presentations, Urofair, Singapore, Singapore Urological Association (International) (08 Mar 2013 - 08 Mar 2013)

SUPERVISION

Postgraduate Student
PhD/ Doctoral
  1. (2016) Biomarker and prognostic indicators in renal cell carcinoma, Yap Ning Yi
  2. (2015) MEASUREMENT AND CLASSIFICATION OF URINARY DIELECTRIC PROPERTIES FOR TYPE 2 DIABETES MELLITUS AND CHRONIC KIDNEY DISEASE, MUN PECK SHEN
  3. (2014) MicroRNA regulation of KDM5B in urothelial cell carcinoma, Radha a/p Kodiappan (M0100103)
Master
  1. (2016) Validation of nocturia quality of life questionnaire, SONG Chun Hoong
  2. (2015) Deciphering of leptin and leptin receptor mechanism in renal cell carcinoma's resistance to targeted therapy, Komathi Perumal
  3. (2014) A randomized controlled trial to compare the effectiveness of pelvic floor exercise with vibrance kegel device (VKD) with pelvic floor exercise alone for stress urinary incontinence in women: a pilot study, JESSE TING
  4. (2013) Establishment and characterisation of Malaysian urothelial cell carcinoma cell lines, LAI JIUN YEE (M0100103)
  5. (2010) DEMOGRAPHICS AND HISTOPATHOLOGY OF PATIENTS UNDERGOING TRANSRECTAL ULTRASOUND (TRUS) GUIDED PROSTATE BIOPSY IN QUEEN ELIZABETH HOSPITAL, KOTA KINABALU, SABAH., Dr Foo Siang Lin
  6. (2010) Colonic stenting versus emergency surgery for left sided malignant colonic obstruction: a single centre retrospective study, Devindran Manoharan
  7. (2008) Molecular Genetics Analysis of Bladder Carcinoma: Gene Expression Profiling and Analysis of the p53 Gene Family, William Ngu Toh Leong (M0100108)
Under Graduate Students
  1. (2023) Practices, Chook Pei Yi, Tan Wooi Chong

TEACHING

Master
  1. (2022) MTA27300 - Advanced Clinical Training
  2. (2022) MTA27400 - Advanced Clinical Training
  3. (2011) UROLOGY - Malaysian Advanced Urology Training Programme
  4. (2010) UROLOGY - Master in Surgery
Bachelor
  1. (2023) MIA3003 - Ummp
  2. (2022) MIA - Bachelor of Medicine, Bachelor of Surgery
  3. (2011) SURGERY - Phase 3a
  4. (2011) SURGERY - Phase 3b
  5. (2010) CLINICAL - Phase 2

SOCIAL RESPONSIBILITY ACTIVITIES

  • Public Health Talk On Nocturia- Pwtc, (21 Nov 2010 - 21 Nov 2010)
  • Public Health Talk On Erectile Dysfunction (Damansara Residence Association), (22 Aug 2010 - 22 Aug 2010)
  • Overactive Bladder & Benign Prostate Enlargement Campaign, (19 Jun 2010 - 20 Jun 2010)